Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Watzinger Norbert |

Presentations at scientific and public conferences

Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment for the Initiation of oral Anticoagulation in non-valvular Atrial Fibrillation: The Self-assessment by the Patient differs from the individual Risk Assessment by means of CHA2DS2-VASc and HASBLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S391-S392. [Poster]
Web of Science

 

Zweiker, D; Rösch, K; Schumacher, M; Stepan, V; Krippl, P; Bauer, N; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Nutzen- und Risikoabschätzung bei Einleitung einer oralen Antikoagulation bei nicht-valvulärem Vorhofflimmern: Die Selbsteinschätzung durch den Patienten differiert von der individuellen Risikobewertung durch CHA2DS2-VASc und HAS-BLED Scores
Wien Klin Wochenschr (2016) 128 [Suppl 5]:S391. 2016; -47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 22-24, 2016; Salzburg, AUSTRIA. [Poster]

 

Zweiker, D; Rosch, K; Schumacher, M; Stepan, V; Krippl, P; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Benefit and Risk Assessment in Initiation of oral Anticoagulant in non valvularem Atrial Fibrillation: A Comparison between Self Assessment by the Patient and an individual Risk Assessment by CHA2DS2VASc and HAS-BLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300. [Poster]
Web of Science

 

Zweiker, D; Rösch, K; Schumacher, M; Stepan, V; Krippl, P; Heine, M; Reicht, G; Zweiker, G; Watzinger, N Nutzen- und Risikoabschätzung bei Einleitung einer oralen Antikoagulation bei nicht-valvulärem Vorhofflimmern: Ein Vergleich zwischen Selbsteinschätzung durch den Patienten und einer individuellen Risikobewertung durch CHA2DS2- VASc und HAS-BLED Scores
WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300. 2016; -Jahrestagung ÖKG; JUN 1-4, 2016; Salzburg, AUSTRIA. [Poster]

 

Gider, P; Schmidt, R; Cavalieri, M; Zweiker, R; Watzinger, N; Schmidt, H CARDIORESPIRATORY FITNESS AND AGE-RELATED BRAIN CHANGES: A COMMUNITY-BASED MRI AND EXERCISE ECG STUDY
Proceedings of the „10th International Conference on AD/PD 2011“2011; -AD/PD 2011; 9-13, 2011; Barcelona, SPAIN. [Oral Communication]

 

Hödl, R; Schmidt, S; Luha, O; Watzinger, N; Stoschitzky, G; Pieske, B; Maier, R X-ray dose, blood loss, dose of radiocontrast agent and renal function in a series of 100 consecutive transcatheter aortic valve implantation patients
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A26-A26. [Poster]
Web of Science

 

Maier, R; Hoedl, R; Stoschitzky, G; Grabenwoeger, M; Pollak, J; Blazek, S; Paetzold, D; Watzinger, N; Pieske, B; Luha, O Feasibility and Durability of Percutaneous Aortic Valve Replacement: 30-day and 1-year Outcomes
CIRCULATION. 2010; 122(2): 0128 [Poster]
Web of Science

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Paetzold, D; Pieske, B; Luha, O One-, two- and three-year outcomes after transcatheter aortic valve implantation: an echocardiographic follow-up study.
Eur J Echocardiography 2010; -Euroecho 2010; DEC 8-11, 2010; Copenhagen, DENMARK. [Poster]

 

Rainer, PP; Schmidt, A; Watzinger, N; Rienmüller, R; Pieske, B Seizures may break the heart – an unusual presentation of stress cardiomyopathy
J f Kardiologie. 2010; -Annual Session of the Austrian Society for Cardiology; JUN 2-5; Salzburg, AUSTRIA. [Poster]

 

Steinwender, G; Szolar, D; Preidler, K; Tillich, M; Zweiker, R; Watzinger, N Diagnostische Wertigkeit der kontrastverstärkten MSCT-Koronarangiografie bei Patienten mit hohem Agatston-score - Vergleich mit der konventionellen Koronarangiografie
Rofo. 2010; 182(2):180-181.-3. Deutsche Kardiodiagnostik-Tage; FEB 25-27, 2010; Stuttgart, GERMANY. [Poster]

 

Steinwender, G; Zweiker, R; Maier, R; Preidler, K; Tillich, M; Szolar, D; Watzinger, N Diagnostic accuracy of contrast-enhanced 64-row MSCT-coronary angiography in patients with severe coronary calcification.
European Heart Journal. 2010; 31(S1):136-136.-European Society of Cardiology; AUG 28 -Sep 1; Stockholm, Sweden. [Poster]
Web of Science

 

Steinwender, G; Zweiker, R; Szolar, D; Preidler, K; Maier, R; Rainer, P; Hödl, R; Tillich, M; Reittner, P; Watzinger, N Diagnostische Genauigkeit der 64-Zeilen-MSCT-Koronarangiographie bei Patienten mit hochgradiger Koronarverkalkung
J Kardiol. 2010; 17(5-6):186-186.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 2-5, 2010; Salzburg, AUSTRIA. [Poster]

 

Blazek, S; Stoschitzky, G; Hodl, R; Patzold, A; Schmidt, A; Watzinger, N; Pieske, B; Luha, O; Maier, R 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A30-A30.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-19, 2009; Vienna, Austria. [Oral Communication]
Web of Science

 

Fruhwald, FM; Kollmann, A; Watzinger, N; Pätzold, D; Stoschitzky, G; Schmidt, A Prognose ambulanter Patienten mit Herzinsuffizienz an der Kardiologie Graz: Daten aus dem Herzinsuffizenz-Register
Journal für Kardiologie2009; 16(5-6):181-181.-Jahrestaung der Österreichischen Kardiologischen Gesellschaft (ÖKG); Juni, 3-6, 2009; Salzburg. [Poster]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement: from feasibility to durability.
Kardiologie 2009 Kongress; MAR 6-7, 2009; Innsbruck, AUSTRIA. 2009. [Poster]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Pieske, B; Luha, O Feasibility and Durability of Percutaneous Aortic Valve Replacement: 30-Day and One-Year Outcomes.
Program & Live Cases iCi & CSI 2009; 146-147.-Congenital & Structural Interventions; JUL 9-11, 2009; Frankfurt, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hödl, R; Watzinger, N; Blazek, S; Schmidt, A; Pätzold, D; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
J Kardiol 2009; 16(5-6):191-191.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 3-6, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Paetzold, D; Pieske, B; Luha, O 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study.
Eur J Echocardiography 2009; 10: -Euroecho 2009; DEC 9-12, 2009; Madrid, SPAIN. [Oral Communication]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Oberwalder, P; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
CRC 2009; - 17th Annual Meeting of the Alpe Adria Association of Cardiology; MAY 8 - 9; Dresden, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Blazek, S; Schmidt, A; Paetzold, D; Oberwalder, P; Pieske, B; Luha, O From feasibility to durability: 30-day and one-year outcomes after percutaneous aortic valve replacement.
Abstractbook 2009; - Joint Meeting (27th Cardiovascular Surgical Symposium & 4th Cardiac Surgery Update and Progress); FEB 28 - MAR 7, 2009; Zuers, AUSTRIA. [Oral Communication]

 

Maier, RM; Hoedl, R; Stoschitzky, G; Watzinger, N; Blazek, S; Oberwalder, PJ; Pieske, BM; Luha, O Percutaneous aortic valve replacement: a new treatment option for high-risk patients with symptomatic severe aortic stenosis.
Eur Surg 2009; 41(Supp):91-92.-50th Annual Meeting of the Austrian Society of Surgery; JUN 18-20, 2009; Vienna, AUSTRIA. [Oral Communication]

 

Steinwender, G; Watzinger, N; Zweiker, R; Berghold, A; Preidler, K; Tillich, M; Szolar, D Diagnostic value of contrast-enhanced MSCT coronary angiography in patients with high Agatston scores: comparison with conventional coronary angiography
WIEN KLIN WOCHENSCHR. . 2009; 121(15-16):A37-A37.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stoschitzky, G; Luha, O; Hoedl, R; Paetzold, D; Schmidt, A; Watzinger, N; Blazek, S; Pieske, B; Maier, R 30-day and one-year outcomes after percutaneous aortic valve replacement: an echocardiographic follow-up study.
Echocardiography Today and Tomorrow; JUN 22-26, 2009; St. Wolfgang, AUSTRIA. 2009. [Poster]

 

Suppan, M; Brussee, H; Kinzl, I; Maier, R; Zweiker, R; Grisold, M; Luha, O; Pieske, B; Pilger, E; Watzinger, N Demographic data for the evaluation of the Styrian ACS Registry for the years 2006-2008
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A37-A37. [Poster]
Web of Science

 

Suppan, M; Brussee, H; Mathyas, K; Maier, R; Zweiker, R; Grisold, M; Luha, O; Hodl, R; Pieske, B; Watzinger, N The supply of acute coronary syndrome (ACS) in Styria: analysis of the data of the Styrian ACS Registry from 2006 to 2008
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A37-A38. [Poster]
Web of Science

 

Maier, R; Hödl, R; Binder, J; Stoschitzky, G; Schmidt, A; Watzinger, N; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Iran Cardiovasc Res J 2008; -2nd Iran-Arab Cardiology Conference; MAR 21-23, 2008; Dubai, UNITED ARAB EMIRATES. [Oral Communication]

 

Maier, R; Hödl, R; Binder, J; Stoschitzky, G; Schmidt, A; Watzinger, N; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement in an 82-year-old patient 17 years after mitral valve replacement.
Iran Cardiovasc Res J 2008; -2nd Iran-Arab Cardiology Conference; MAR 21-23, 2008; Dubai, UNITED ARAB EMIRATES. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: an emerging new treatment option for high-risk patients.
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A53-A53.- 39. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 17-20, 2008; Graz, AUSTRIA. [Poster]
Web of Science

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Binder, J; Oberwalder, P; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: An emerging new treatment option for high-risk patients.
J Kardiol 2008; 15(5-6):187(2)-187(2).-Jahrestagung der Österreichischen Kardiologischen Gesellschft; MAY 28-31, 2008; Salzburg, AUSTRIA. [Poster]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Blazek, S; Oberwalder, P; Pieske, B; Luha, O Percutaneous Aortic Valve Replacement: A New Treatment Option for High-Risk Patients with Symptomatic Severe Aortic Stenosis.
Lijec Vjesn 2008; 130: 76-77.- 7th Congress of the Croatian Cardiac Society; OCT 16-19, 2008; Opatija, CROATIA. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Cardiac Surgery Update and Progress - CSUP; MAR 29 - APR 5, 2008; Lech, AUSTRIA. 2008. [Oral Communication]

 

Maier, R; Hödl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis in high-risk patients: Initial experience with the CoreValve ReValvingTM system.
Cardiac Surgery Update and Progress - CSUP; MAR 29 - APR 5, 2008; Lech, AUSTRIA. 2008. [Poster]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O Percutaneous aortic valve replacement: an emerging new treatment option for high-risk patients with severe symptomatic aortic stenosis.
Arch Cardiol Méx 2008; 78(Supp):3-5.- XIV Congreso de la Sociedad Latinoamericana de Cardiologia Intervencionista (SOLACI); AUG 6-8, 2008; Cancun, MEXICO. [Oral Communication]

 

Maier, R; Hoedl, R; Stoschitzky, G; Watzinger, N; Schmidt, A; Binder, J; Oberwalder, P; Brussee, H; Pieske, B; Luha, O Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: an emerging new treatment option for high-risk patients.
Eur Heart J 2008; 29(Supp):62-63.- Congress of the European Society of Cardiology; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Maier, R; Stoschitzky, G; Hoedl, R; Watzinger, N; Schmidt, A; Blazek, S; Pieske, B; Luha, O Percutaneous aortic valve replacement: echocardiography for patient selection and follow-up.
Eur J Echocardiography 2008; 9(Supp):S136-S136.- Euroecho 2008; DEC 10-13, 2008; Lyon, FRANCE. [Poster]

 

Maier, RM; Hoedl, R; Stoschitzky, G; Watzinger, N; Schmidt, AG; Blazek, S; Oberwalder, PJ; Pieske, B; Luha, O Percutaneous Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis in High-Risk Patients: One-Year Experience with the CoreValve Revalving (TM) System
AMER J CARDIOL. 2008; 102(8A):235I-235I.-12th Annual Transcatheter Cardiovascular Therapeutics Conference; OCT 12-17, 2008; Washington, DC, USA.
Web of Science

 

Stoschitzky, G; Hödl, R; Watzinger, N; Oberwalder, P; Pieske, B; Luha, O; Maier, R Percutaneous aortic valve replacement for severe symptomatic aortic stenosis: Patient selection and management.
J Kardiol 2008; 15(5-6):187(1)-187(1).-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 28-31, 2008; Salzburg, AUSTRIA. [Poster]

 

Mahla, E; Archan, S; Baumann, A; Watzinger, N Präoperative Evaluierung oder postoperatives Monitoring?
Proceedings der eingeladenen Vorträge und eingesandten Abstracts.2007; 57(S2):54-55.-Austrian International Congress; SEP 5-7, 2007; Vienna, AUSTRIA. [Oral Communication]

 

Maier, R; Haemmerle, G; Gorkiewicz, G; Watzinger, N; Haumer, A; Braunias, H; Gasser, R; Brussee, H; Hoefler, G; Zechner, R Echocardiographic phenotyping in a transgenic mouse model.
Echocardiography Today and Tomorrow; JUN 25-29, 2007; St. Wolfgang, AUSTRIA. 2007. [Poster]

 

Maier, R; Mavriqi, F; Luha, O; Paetzold, D; Watzinger, N; Stoschitzky, G; Gamillscheg, A; Niederkorn, K; Beitzke, A; Horner, S Incidence of recurrent cerebral embolic events after patent foramen ovale and atrial septal defect transcatheter closure.
Eur Heart J 2007; 28(Supp):452-452.-Congress of the European Society of Cardiology; SEP 1-5, 2007; Vienna, AUSTRIA. [Poster]

 

Stoschitzky, G; Lercher, P; Maier, R; Watzinger, N; Fruhwald, FM; Zweiker, R; Brussee, H; Stoschitzky, K Long-term administration of nebivolol does not cause nitrate tolerance.
EUR J HEART FAIL. 2007; 6: 116-117.-Heart Failure 2007; JUN 9-12, 2007; Hamburg, Germany. Doi: 10.1016/S1567-4215(07)60325-7 [Poster]
Web of Science FullText FullText_MUG

 

Stoschitzky, G; Maier, R; Lercher, P; Brussee, H; Zweiker, R; Watzinger, N; Fruhwald, FM; Stoschitzky, K Different beta-blocking effects of metoprolol, bisoprolol and carvedilol.
EUR J HEART FAIL. 2007; 6: 122-122.-Heart Failure 2007; JUN 9-12, 2007; Hamburg, Germany. Doi: 10.1016/S1567-4215(07)60342-7 [Poster]
Web of Science FullText FullText_MUG

 

Stoschitzky, K; Stoschitzky, G; Zweiker, R; Maier, R; Lercher, P; Watzinger, N; Fruhwald, FM; Brussee, H Different beta-blockers show different effects.
CARDIOVASC DRUG THERAPY. 2007; 21: S12-S12. [Poster]
Web of Science

 

Wallner, SJ; Horejsi, R; Zweiker, R; Watzinger, N; Moller, R; Schnedl, W; Schauenstein, K; Tafeit, E ROC analysis of subcutaneous adipose tissue topography (SAT-Top) Efficiently discriminates female coronary heart disease patients from healthy controls, irrespective of BMI
INT J OBESITY. 2007; 31: S78-S78.-15th European Congress on Obesity (ECO); APR 22-25, 2007; Budapest, Hungary. [Poster]
Web of Science

 

Lileg, B; Schmid, M; Watzinger, N; Samonigg, H Myocardial infection after chemotherapy for testicular cancer: A cumulative case report.
Wiener Medizinische Wochenschrift. 118: 14-14.-ÖGHO; May, 2006; Wels, Austria. [Poster]

 

Maier, R; Haemmerle, G; Gorkiewicz, G; Watzinger, N; Haumer, A; Braunias, H; Gasser, R; Brussee, H; Hoefler, G; Zechner, R Echocardiographic phenotyping in a transgenic mouse model.
J Kardiol 2006; 13(5-6):202-202.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN 7-10, 2006; Salzburg, AUSTRIA. [Poster]

 

Maier, R; Haemmerle, G; Gorkiewicz, G; Watzinger, N; Haumer, A; Braunias, H; Gasser, R; Brussee, H; Hoefler, G; Zechner, R Echocardiographic Phenotyping in a Transgenic Mouse Model
J Kardiol 2006; 13(11):372-372.-Mayo & Vienna: Contemporary Clinical Cardiology; SEP 14-16, 2006; Vienna, AUSTRIA. [Poster]

 

Maier, R; Haemmerle, G; Gorkiewicz, G; Watzinger, N; Haumer, A; Braunias, H; Hoefler, G; Zechner, R Echocardiographic phenotyping in a transgenic mouse model
Eur J Echocardiography 2006; 7(Supp):S193-S193.-EUROECHO 10; DEC 6-9, 2006; Prague, CZECH REPUBLIC. [Poster]

 

Maier, R; Mavriqi, F; Luha, O; Paetzold, D; Watzinger, N; Stoschitzky, G; Stein, JI; Gamillscheg, A; Thaler, D; Pichler, G; Beitzke, M; Brussee, H; Niederkorn, K; Beitzke, A; Horner S Incidence of recurrent cerebral embolic events after patent foramen ovale and atrial septal defect transcatheter closure.
J Kardiol . 2006; 13(5-6):183-183.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; JUN, 7-10, 2006; Salzburg, AUSTRIA. [Oral Communication]

 

Wonisch, M; Lercher, P; Scherr, D; Kraxner, W; Maier, R; Fruhwald, FM; Rotman, B; Watzinger, N The impact of av optimized rv pacing in patients with implanted cardioverter-defibrillators and reduced compared to preserved left ventricular function
EUR HEART J. 2006; 27: 463-463.-European Society of Cardiology Congress; SEP 3-7, 2006; Barcelona, Spain. [Poster]
Web of Science

 

Maier, R; Luha, O; Paetzold, D; Watzinger, N; Stein, JI; Niederkorn, K; Beitzke, A; Horner, S Incidence of thrombus formation on patent foramen ovale and atrial septal defect closure devices
EUR HEART J. 2005; 26: 558-558.
Web of Science

 

Maier, R; Luha, O; Pätzold, D; Watzinger, N; Stein, JI; Gamillscheg, A; Thaler, D; Pichler, G; Beitzke, M; Brussee, H; Niederkorn, K; Beitzke, A; Horner, S Incidence of thrombus formation on patent foramen ovale and atrial septal closure devices.
J Kardiol 2005; 12(5-6):106-106.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft ; Jun 1-4, 2005; Salzburg, AUSTRIA. [Oral Communication]

 

Wonisch, M; Lercher, P; Scherr, D; Maier, R; Fruhwald, FM; Watzinger, N; Rotman, B; Klein, WW Negative influence of permanent right ventricular pacing on cardio-respiratory exercise parameters in chronic heart failure patients with implanted cardioverter defibrillators
EUR HEART J 2004 25: 646-646. [Oral Communication]
Web of Science

 

Fruhwald, F; Watzinger, N; Maier, R; Wonisch, M; Klein, W; Rehak, P Spironolactone in patients with heart failure. Results from the Austrian Survey of Treating Heart Failure (AUSTRIA)
EUR HEART J 2003 24: 527-527. Doi: 10.1016/S0195-668X(03)95577-1
Web of Science FullText FullText_MUG

 

Koshucharova, G; Stoschitzky, K; Zweiker, R; Lercher, P; Maier, R; Watzinger, N; Klein, W Different effects of propranolol, bisoprolol, carvedilol and doxazosin.
CLIN PHARMACOL THER 2003 73: P63-P63. Doi: 10.1016/S0009-9236(03)90589-3
Web of Science FullText FullText_MUG

 

Maier, R; Fruhwald, F; Wonisch, M; Watzinger, N; Klein, W; Rehak, P Heart failure treatment in the real world: the Austrian survey of treating heart failure (AUSTRIA)
EUR HEART J 2003 24: 290-290. Doi: 10.1016/S0195-668X(03)94728-2
Web of Science FullText FullText_MUG

 

Wonisch, M; Hofmann, P; Kranz, S; Kraxner, W; Watzinger, N; Maier, R; Fruhwald, F; Klein, W Relationship of various haemodynamic parameters to the anaerobic threshold during upright cyle ergometer exercise
EUR HEART J 2003 24: 626-626. Doi: 10.1016/S0195-668X(03)95922-7
Web of Science FullText FullText_MUG

 

Koshucharova, G; Stoschitzky, K; Zweiker, R; Maier, R; Watzinger, N; Klein, W Different beta-blocking effects of carvedilol and metoprolol.
CLIN PHARMACOL THER 2001 69: P34-P34.
Web of Science

 

Stoschitzky, K; Koshucharova, G; Zweiker, R; Fruhwald, FM; Maier, R; Watzinger, N; Lercher, P; Klein, W Different beta-blocking effects of metoprolol, bisoprolol and carvedilol in humans
EUR HEART J 2001 22: 299-299. Doi: 10.1016%2FS1388-9842%2801%2900126-X
Web of Science FullText FullText_MUG

 

Watzinger, N; Lund, GK; Chujo, M; Saeed, M; Higgins, CB Long-term effects of oral nicorandil therapy on post-infarction left ventricular remodelling in rats: in vivo assessment using MR imaging
EUR HEART J 2001 22: 176-176.
Web of Science

 

Watzinger, N; Lund, GK; Higgins, CB; Chujo, M; Saeed, M Noninvasive assessment of the effects of nicorandil therapy on left ventricular remodeling in rats
CIRCULATION 2001 104: 722-722.
Web of Science

 

Watzinger, N; Lund, GK; Saeed, M; Higgins, CB A novel MR imaging strategy for predicting post-infarction left ventricular remodelling: assessment in a rat model
EUR HEART J 2001 22: 6-6.
Web of Science

 

Fruhwald, FM; Fahrleitner, A; Maier, R; Watzinger, N; Klein, W Long-term treatment of pulmonary hypertension with inhaled iloprost and its effect on natriuretic peptides
EUR HEART J 2000 21: 596-596.
Web of Science

 

Zweiker, R; Hogler, S; Schumacher, M; Fruhwald, FM; Watzinger, N; Gasser, RNA; Klein, W Comparison of wrist blood pressure measurement with conventional sphygmomanometry at a cardiology out-patient department
J HYPERTENSION 2000 18: S38-S38. Doi: 10.1097/00004872-200006001-00119
Web of Science FullText FullText_MUG

 

Watzinger, N; Schumacher, M; Schmidt, R; Schmidt, H; Eber, B; Fruhwald, FM; Zweiker, R; Kostner, GM; Klein, WW Angiotensinogen M235T polymorphism in patients with risk of coronary artery disease
CIRCULATION 1999 100: 822-822.
Web of Science

 

Schmidt, H; Schmidt, R; Fazekas, F; Schumacher, M; Kapeller, P; Watzinger, N; Hartung, HP; Kostner, GM The Met-Leu54 polymorphism is associated with progression of microangiopathy-related cerebral abnormalities (MARCA)on MRI: 3-year follow-up results of the Austrian Stroke Prevention Study
CIRCULATION. 1998; 98: 30-30.-American Heart Association Meeting;
Web of Science

 

Schumacher, M; Watzinger, N; Schmidt, R; Schmidt, H; Eber, B; Fruhwald, FM; Zweiker, R; Kostner, GM; Klein, W The paroxonase polymorphism Met-Leu54 in patients with disk for coronary heart disease
CIRCULATION 1998 98: 532-532.
Web of Science

 

Wallner, S; Watzinger, N; Lindschinger, M; Wascher, TC; Toplak, H; Smolle, KH; Elmadfa, I; Eber, B; Klein, W; Krejs, GJ Effects of intensified lifestyle modification on clinical restenosis after coronary angioplasty
ATHEROSCLEROSIS 1997 134: 268-268. Doi: 10.1016/S0021-9150(97)89410-5
Web of Science FullText FullText_MUG

 

Habersack-Wallner, S; Lindschinger, M; Krachler, M; Toplak, H; Watzinger, N; Klein, W; Elmadfa, I Spurenelementstatus und Aktivität antioxidativer Enzyme bei Patienten mit koronarer Herzkrankheit und PTCA - eine Analyse.
Acta Medica Austriaca. 23(S1):34-34.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; Linz.

 

Schumacher, M; Mostl, B; Semlitsch, B; Fruhwald, F; Pokan, R; Zweiker, R; Watzinger, N; Eber, B; Klein, W; Pieber, T Diastolic dysfunction and heart rate variability in patients with diabetes mellitus type I
DIABETOLOGIA 1996 39: 967-967.
Web of Science

 

Watzinger, N; Schumacher, M; Mostl, B; Semlitsch, B; Eber, B; Fruhwald, F; Zweiker, R; Pokan, R; Klein, W; Pieber, T QTc period measured by a 24-hour Holter recording system in diabetic autosomic neuropathy
DIABETOLOGIA 1996 39: 955-955.
Web of Science

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint